In colorectal cancer (CRC), mutations in K-ras and p53 result in constitutive activation of MAPK and phosphatidylinositol 3-kinase (PI3K) signaling, which leads to enhanced TF expression. The gene discussed is TF; the disease is colorectal carcinoma.